Company Overview of H-Phar S.A.
H-PHAR SA operates as a pharmaceutical research company in Belgium. It engages in preclinical research for the development of anti-viral applications in the domain of hemorrhagic fever and oncoviruses, and immune-modulator drugs inhibiting graft rejection; clinical development of anti-HIV drugs; and synthesis and evaluation of biological activities of low molecular weight azo-compounds. The company was founded in 2002 and is based in Gosselies, Belgium.
Rue Clément Ader 12
Gosselies , 6041
Founded in 2002
32 7 135 76 57
32 7 135 76 57
Key Executives for H-Phar S.A.
Similar Private Companies By Industry
|Immo Desimpel N.V.||Europe|
|Integrated DNA Technologies, BVBA||Europe|
|Omega Pharma Invest NV||Europe|
|Omrix Biopharmaceuticals S.A.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Oct 22
- Bridgewater, NJ | InformaticaPosted: Dec 11
- Parsippany, NJ | RGPPosted: Dec 13
- Parsippany, NJ | RGPPosted: Nov 27
Sponsored Financial Commentaries
To contact H-Phar S.A., please visit www.h-phar.com. Company data is provided by Capital IQ. Please use this form to report any data issues.